• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT HBSAG QUALITATIVE II CONFIRMATORY REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT HBSAG QUALITATIVE II CONFIRMATORY REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 02G23-25
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/02/2022
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product, list number 02g23 that has a similar product distributed in the us, list number 04p54.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed false positive architect hbsag qualitative ii confirmatory result for one patient.The customer had some imprecision issue with this assay and therefore decided to repeat the confirmatory testing.The repeated confirmatory result was negative.The following data was provided: sid (b)(6) hbsag initial result = 2.14 s/co (reactive), repeat results = 1.10 s/co (reactive), 1.04 s/co (reactive).Initial hbsag confirmatory result: hbsag %n = 76%, hbsag c2 result = 3.97 s/co (positive) repeat hbsag confirmatory result: hbsag %n =15%, hbsag c2 result = 1.33 s/co (negative) additional lab results provided: anti- hbc = nonreactive the customer believed the negative hbsag confirmatory is the correct result.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation false reactive architect hbsag quantitative ii confirmatory result included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, and labeling review.In-house testing of retained reagent kit was also completed.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.Ticket search by lot indicates that the reagent lot performs as expected for this product.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot number 34477fn00 and complaint issue.Labeling was reviewed and sufficiently addresses the customer's issue.In-house testing of a retained reagent kit of the complaint lot 34477fn00 was performed.All specifications were met which indicates the lot is performing acceptably.In this case, sample integrity issues or a preanalytical error with the initial testing could have contributed to the customer¿s observation.Per product labeling, if the architect hbsag qualitative ii confirmatory results are inconsistent with clinical evidence, additional testing is suggested to confirm the result.For diagnostic purposes, results should be used in conjunction with patient history and other hepatitis markers for diagnosis of acute and chronic infection.Based on this investigation, no systemic issue or deficiency with the architect hbsag quantitative ii confirmatory reagent, lot number 34477fn00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HBSAG QUALITATIVE II CONFIRMATORY REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key15481801
MDR Text Key301004038
Report Number3008344661-2022-00113
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P110029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/25/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/08/2022
Device Catalogue Number02G23-25
Device Lot Number34477FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/07/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2K PROC MOD, 03M74-01, (B)(6) ; ARC I2K PROC MOD, 03M74-01, (B)(6)
-
-